ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis

Author： Cavero Icilio   Crumb William  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 509-530

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of Guideline-Recommended Cardiac Drugs for Reducing Mortality in the Elderly Medicare Heart Failure Population: A Retrospective, Survey-Weighted, Cohort Analysis

By Richardson Diane M.  

Drugs & Aging, Vol. 27, Iss. 10, 2010-10 ,pp. : 845-854

Adis International

Access to resources Recommend Favorite

Drugs, QTc Interval Prolongation and Final ICH E14 Guideline: An Important Milestone with Challenges Ahead

By Shah Rashmi R.  

Drug Safety, Vol. 28, Iss. 11, 2005-01 ,pp. : 1009-1028

Adis International

Access to resources Recommend Favorite

Non-Systemic Drugs: A Critical Review

By  

Current Pharmaceutical Design, Vol. 18, Iss. 10, 2012-04 ,pp. : 1434-1445

Bentham Science Publishers

Access to resources Recommend Favorite

Joint EFPIA/CHMP SWP workshop: the Emerging Use of Omic Technologies for Regulatory Non-Clinical Safety Testing

By Kasper Peter   Oliver Gerry   Lima Beatriz Silva   Singer Thomas   Tweats David  

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 181-184

Future Medicine

Access to resources Recommend Favorite

Risk of sudden cardiac death with commonly prescribed drugs

By  

Reactions Weekly, Vol. 1, Iss. 1052, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite